Discovery of Novel Covalent Inhibitors of DJ-1 Through Hybrid Virtual Screening

References

• Nagakubo D , TairaT, KitauraHet al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Comm.231(2), 509–513 (1997).
   PubMed Web of Science ®Google Scholar
• Zhang L , WangJ, WangJ, YangB, HeQ, WengQ. Role of DJ-1 in immune and inflammatory diseases. Front. Immunol.11, 994 (2020).
   PubMedGoogle Scholar
• Tsuchiya B , IwayaK, KohnoNet al. Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast. Histopathology61(1), 69–77 (2012).
   PubMed Web of Science ®Google Scholar
• Smith N , WilsonMA. Structural biology of the DJ-1 superfamily. In: Dj-1/Park7 Protein: Parkinson’s Disease, Cancer and Oxidative Stress-Induced Diseases.ArigaH, IguchiarigaSMM ( Eds). Springer, NY, USA, 5–24 (2017).
   Google Scholar
• Jung HJ , KimS, KimYJet al. Dissection of the dimerization modes in the DJ-1 superfamily. Mol. Cells33(2), 163–171 (2012).
   PubMed Web of Science ®Google Scholar
• Wilson MA , CollinsJL, HodY, RingeD, PetskoGA. The 1.1-angstrom resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson’s disease. Proc. Natl Acad. Sci. USA100(16), 9256–9261 (2003).
   PubMed Web of Science ®Google Scholar
• Takahashi K , TairaT, NikiT, SeinoC, Iguchi-ArigaSMM, ArigaH. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem.276(40), 37556–37563 (2001).
   PubMed Web of Science ®Google Scholar
• Taplin ME , BubleyGJ, KoYJet al. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res.59(11), 2511–2515 (1999).
   PubMed Web of Science ®Google Scholar
• Neves M , GraosM, AnjoSI, ManadasB. Modulation of signaling pathways by DJ-1: an updated overview. Redox Biol.51, 102283 (2022).
   PubMed Web of Science ®Google Scholar
• Yanagisawa D , KitamuraY, IndenMet al. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J. Cerebr. Blood Flow Metab.28(3), 563–578 (2008).
   PubMed Web of Science ®Google Scholar
• An CN , JiangH, WangQet al. Down-regulation of DJ-1 protein in the ejaculated spermatozoa from Chinese asthenozoospermia patients. Fertil. Steri.96(1), 19-U652 (2011).
   Web of Science ®Google Scholar
• Waak J , WeberSS, GornerKet al. Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. J. Biol. Chem.284(21), 14245–14257 (2009).
   PubMed Web of Science ®Google Scholar
• Kawate T , IwayaK, KoshikawaKet al. High levels of DJ-1 protein and isoelectric point 6.3 isoform in sera of breast cancer patients. Cancer Sci.106(7), 938–943 (2015).
   PubMed Web of Science ®Google Scholar
• Tao X , TongL. Crystal structure of human DJ-1, a protein associated with early onset Parkinson’s disease. J. Biol. Chem.278(33), 31372–31379 (2003).
   PubMed Web of Science ®Google Scholar
• Zeng HZ , QuYQ, ZhangWJ, XiuB, DengAM, LiangAB. Proteomic analysis identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer. Int. J. Mol. Sci.12(6), 3489–3499 (2011).
   PubMed Web of Science ®Google Scholar
• Tsoporis JN , DrosatosIA, GuptaSet al. Cytoprotective mechanisms of DJ-1: implications in cardiac pathophysiology. Molecules26(13), 3795 (2021).
   PubMed Web of Science ®Google Scholar
• Kinumi T , KimataJ, TairaT, ArigaH, NikiE. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Comm.317(3), 722–728 (2004).
   PubMed Web of Science ®Google Scholar
• Hijioka M , IndenM, YanagisawaD, KitamuraY. DJ-1/PARK7: a new therapeutic target for neurodegenerative disorders. Biol. Pharmac. Bull.40(5), 548–552 (2017).
   PubMed Web of Science ®Google Scholar
• Cao J , ChenXB, YingMD, HeQJ, YangB. DJ-1 as a therapeutic target against cancer. In: Dj-1/Park7 Protein: Parkinson’s Disease, Cancer and Oxidative Stress-Induced Diseases.ArigaH, IguchiarigaSMM ( Eds). Springer, NY, USA, 203–222 (2017).
   Google Scholar
• Trivedi R , DihaziGH, EltoweissyM, MishraDP, MuellerGA, DihaziH. The antioxidant protein PARK7 plays an important role in cell resistance to cisplatin-induced apoptosis in case of clear cell renal cell carcinoma. Eur. J. Pharmacol.784, 99–110 (2016).
   PubMed Web of Science ®Google Scholar
• He X , SunY, FanR, SunJ, ZouD, YuanY. Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition. Mol. Ther. Oncolytics20, 364–372 (2021).
   PubMed Web of Science ®Google Scholar
• Kitamura Y , WatanabeS, TaguchiMet al. Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson’s disease and stroke model rats. Mol. Neurodegen.6(1), 1–19 (2011).
   PubMedGoogle Scholar
• Tashiro S , CaaveiroJM, NakakidoMet al. Discovery and optimization of inhibitors of the Parkinson’s disease associated protein DJ-1. ACS Chem. Biol.13(9), 2783–2793 (2018).
   PubMed Web of Science ®Google Scholar
• Chen X-B , ZhuH-Y, BaoKet al. Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors. Acta Pharmacol. Sinica42(7), 1160–1170 (2021).
   PubMed Web of Science ®Google Scholar
• ChemDiv . Screening Libraries. Chemical Libraries (2021). www.chemdiv.com/catalog/screening-libraries/
   Google Scholar
• Enamine Ltd . COMPOUND LIBRARIES (2021). https://enamine.net/compound-libraries
   Google Scholar
• Specs . Research Compounds (2021). www.specs.net/index.php?page=2019041215290210#researchcompounds
   Google Scholar
• Chemical Abstracts Service . SciFinder chemical library. SciFinder-n (2021). https://scifinder.cas.org/scifinder
   Google Scholar
• TargetMol . Compound Libraries (2021). www.targetmol.com/all-compound-libraries
   Google Scholar
• Life Chemicals . Covalent Inhibitor Libraries (2021). https://lifechemicals.com/screening-libraries/covalent-inhibitor-libraries/
   Google Scholar
• Tashiro S , CaaveiroJMM, NakakidoMet al. Discovery and optimization of inhibitors of the Parkinson’s disease associated protein DJ-1. ACS Chem. Biol.13(9), 2783–2793 (2018).
   PubMed Web of Science ®Google Scholar
• Berman HM , WestbrookJ, FengZet al. The Protein Data Bank. Nucleic Acids Res.28(1), 235–242 (2000).
   PubMed Web of Science ®Google Scholar
• Harder E , DammW, MapleJet al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J. Chem. Theory Comp.12(1), 281–296 (2016).
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry G , AdzhigireyM, DayT, AnnabhimojuR, ShermanW. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Computer-Aided Mol. Design27, 221–234 (2013).
   PubMed Web of Science ®Google Scholar
• Friesner RA , BanksJL, MurphyRBet al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem.47(7), 1739–1749 (2004).
   PubMed Web of Science ®Google Scholar
• Genheden S , RydeU. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov.10(5), 449–461 (2015).
   PubMed Web of Science ®Google Scholar
• Duan J , DixonSL, LowrieJF, ShermanW. Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods. J. Mol. Graphics Model.29(2), 157–170 (2010).
   PubMed Web of Science ®Google Scholar
• Dixon SL , SmondyrevAM, KnollEH, RaoSN, ShawDE, FriesnerRA. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J. Computer-Aided Mol. Design20, 647–671 (2006).
   PubMed Web of Science ®Google Scholar
• Zhu K , BorrelliKW, GreenwoodJRet al. Docking covalent inhibitors: a parameter free approach to pose prediction and scoring. J. Chem. Informat. Model.54(7), 1932–1940 (2014).
   PubMed Web of Science ®Google Scholar
• RDKit: Open-source cheminformatics RDKit . https://www.rdkit.org
   Google Scholar
• Bateman A , MartinMJ, OrchardSet al. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res.51(D1), D523–D531 (2023).
   PubMed Web of Science ®Google Scholar
• Wilson MA . The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid. Redox Signal.15(1), 111–122 (2011).
   PubMed Web of Science ®Google Scholar
• Xu YJ , WangSW, HuQWet al. CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction. Nucleic Acids Res.46(W1), W374–W379 (2018).
   PubMed Web of Science ®Google Scholar
• Witt AC , LakshminarasimhanM, RemingtonBC, HasimS, PozharskiE, WilsonMA. Cysteine pK(a) depression by a protonated glutamic acid in human DJ-1. Biochemistry47(28), 7430–7440 (2008).
   PubMed Web of Science ®Google Scholar
• Baillie TA . Targeted covalent inhibitors for drug design. Angew. Chem. Int. Ed. Engl.55(43), 13408–13421 (2016).
   PubMed Web of Science ®Google Scholar
• Allen FH , KennardO, WatsonDG, BrammerL, OrpenAG, TaylorR. Tables of bond lengths determined by x-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. J. Chem. Soc., Perkin Transact.2(12), S1–S19 (1987).
   Google Scholar
• Black K , LiuP, XuL, DoubledayC, HoukKN. Dynamics, transition states, and timing of bond formation in Diels-Alder reactions. Proc. Natl Acad. Sci. USA109(32), 12860–12865 (2012).
   PubMed Web of Science ®Google Scholar
• Schrödinger, LLC . The PyMOL Molecular Graphics System, Version 2.5.4. https://pymol.org/2/
   Google Scholar
• Laskowski RA , SwindellsMB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.J. Chem. Inf. Model.51(10), 2778–2786 (2011).
   PubMed Web of Science ®Google Scholar
• Sitaram RT , CairneyCJ, GrabowskiPet al. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int. J. Cancer125(4), 783–790 (2009).
   PubMed Web of Science ®Google Scholar
• Brodaczewska KK , SzczylikC, FiedorowiczM, PortaC, CzarneckaAM. Choosing the right cell line for renal cell cancer research. Mol. Cancer15(1), 83 (2016).
   PubMedGoogle Scholar
• White BD , ChienAJ, DawsonDW. Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers. Gastroenterology142(2), 219–232 (2012).
   PubMed Web of Science ®Google Scholar
• Jin F , WangH, LiDet al. DJ-1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/beta-catenin signaling pathway. Int. J. Oncol.56(5), 1115–1128 (2020).
   PubMed Web of Science ®Google Scholar